LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ELI LILLY AND COMPANY (an Indiana corporation) and VANDA PHARMACEUTICALS INC. (a Delaware corporation) Dated as of April 12, 2012License, Development and Commercialization Agreement • August 3rd, 2012 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
This LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (“Agreement”), effective as of April , 2012 (“Effective Date”) is entered into by and between Vanda Pharmaceuticals Inc., a Delaware corporation, with offices at 2200 Pennsylvania Avenue, NW, Suite 300E, Washington, DC 20037 and its Affiliates (collectively, “Vanda”) and Eli Lilly and Company, an Indiana corporation, with offices at Lilly Corporate Center, Indianapolis, Indiana 46285 and its Affiliates (collectively, “Lilly”). Lilly and Vanda may be referred to as a “Party” or together, the “Parties”.
